SARS-CoV-2 Spike Protein and Lung Vascular Cells
Journal of Respiration · 2020
DOI: 10.3390/jor1010004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Respiration, 2020. Verfasst von Sri Jayalakshmi Suresh und 1 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current pandemic of coronavirus disease 2019 (COVID-19), and COVID-19 vaccines focus on its spike protein. However, in addition to facilitating the membrane fusion and viral entry, the SARS-CoV-2 spike protein promotes cell growth signaling in human lung vascular cells, and patients who have died of COVID-19 have thickened pulmonary vascular walls, linking the spike protein to a fatal disease, pulmonary arterial hypertension (PAH). In addition to SARS-CoV spike proteins, gp120, the viral membrane fusion protein of human immunodeficiency virus (HIV), has been reported to promote cell signaling, and long-term surviving HIV-positive patients have a high incidence of developing PAH. This article describes the findings of the SARS-CoV-2 spike protein affecting lung vascular cells and explains how the spike protein possibly increases the incidence of PAH. Since the SARS-CoV-2 spike protein will be administered to millions of people as COVID-19 vaccines, it is critical to understand the biological effects of this protein on human cells to ensure that it does not promote long-term adverse health consequences.
Förderung
- National Institutes of Health
Zitieren
APA
Suresh, S. J., & Suzuki, Y. J. (2020). SARS-CoV-2 Spike Protein and Lung Vascular Cells. Journal of Respiration. https://doi.org/10.3390/jor1010004
Vancouver
Suresh SJ, Suzuki YJ. SARS-CoV-2 Spike Protein and Lung Vascular Cells. Journal of Respiration. 2020. doi:10.3390/jor1010004
BibTeX
@article{Suresh2020,
author = {Suresh, Sri Jayalakshmi and Suzuki, Yuichiro Justin},
title = {SARS-CoV-2 Spike Protein and Lung Vascular Cells},
journal = {Journal of Respiration},
year = {2020},
doi = {10.3390/jor1010004}
}
EUVIMED